US Stock MarketDetailed Quotes

ALPMY Astellas Pharma (ADR)

Watchlist
  • 9.550
  • +0.010+0.10%
15min DelayClose Apr 26 16:00 ET
17.12BMarket Cap561.76P/E (TTM)

Astellas Pharma (ADR) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Astellas Pharma (ADR) Earnings Date

Currency: JPY

Period

Q3 FY2024 Earnings

Feb 5, 2024

Revenue(YoY)

421.93B

+4.91%
EPS(YoY)

8.06

-69.64%
Analyst Rating

No Data

Astellas Pharma (ADR) Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 428.866B--
--2025/Q1-- / 408.629B--
Apr 25, 20242024/Q4414.602B / 381.093B--
Feb 5, 20242024/Q3421.932B / 385.383B--
Nov 1, 20232024/Q2392.148B / 355.602B--
Aug 1, 20232024/Q1374.990B / 357.906B--
Apr 27, 20232023/Q4354.254B / 361.045B--
Feb 6, 20232023/Q3402.180B / 395.900B--
Oct 31, 20222023/Q2380.394B / 360.355B--
Aug 1, 20222023/Q1381.791B / 345.350B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 428.866B--
--2025/Q1-- / 408.629B--
Apr 25, 20242024/Q4414.602B / 381.093B--
Feb 5, 20242024/Q3421.932B / 385.383B--
Nov 1, 20232024/Q2392.148B / 355.602B--
Aug 1, 20232024/Q1374.990B / 357.906B--
Apr 27, 20232023/Q4354.254B / 361.045B--
Feb 6, 20232023/Q3402.180B / 395.900B--
Oct 31, 20222023/Q2380.394B / 360.355B--
Aug 1, 20222023/Q1381.791B / 345.350B--

Unlock Free Earnings Estimates

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg